Kezar’s Lead Asset Bounces Back With Lupus Win

Following Myositis Setback

 
• By Ayisha Sharma
  
The Results Hit The Benchmark Touted By Some Analysts • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D